The Orai Ca2+ channel inhibitor CM4620 targets both parenchymal and immune cells to reduce inflammation in experimental acute pancreatitis

CRAC Channels And Disease – From Human CRAC Channelopathies And Animal Models To Novel Drugs

Microglial Calcium Release-Activated Calcium Channel Inhibition Improves Outcome from Experimental Traumatic Brain Injury and Microglia-Induced Neuronal Death

CRAC channels as targets for drug discovery and development

Ca2+ signalling underlying pancreatitis

Scroll to Top
Scroll to Top